Split dose ATG strategy prevents grade III-IV acute GVHD and is associated with immune surrogates of GVL
Zaid Al-Kadhimi1, Samuel Pirruccello2, Zartash Gul3
1Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA. zaid.alkadhimi@unmc.edu.
Bone Marrow Transplantation
|August 11, 2022
Abstract
No abstract available in PubMed .
More Related Videos
10:29Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
Published on: August 29, 2012
15.8K
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
7.2K
Related Concept Videos
01:40Cell-mediated Immune Responses
70.4K
Overview
70.4K
01:22Bone Marrow Sampling and Transplants
483
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
483